Adult weight gain and adiposity-related cancers: A dose-response meta-analysis of prospective observational studies

Journal of the National Cancer Institute

Volumn 107, Issue 2, 2015, Pages

  Keum, Nana ^a   Greenwood, Darren C ^b   Lee, Dong Hoon ^a   Kim, Rockli ^a   Aune, Dagfinn ^c,d   Ju, Woong ^e   Hu, Frank B ^a,f   Giovannucci, Edward L ^a,f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e Ewha Womans University   (South Korea)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RISK; COLON CANCER; EMBASE; ENDOMETRIUM CANCER; HORMONE SUBSTITUTION; HUMAN; KIDNEY CANCER; MEDLINE; META ANALYSIS; NEOPLASM; OBESITY; OVARY CANCER; PANCREAS CANCER; POSTMENOPAUSE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; SYSTEMATIC REVIEW; THYROID CANCER; WEIGHT GAIN; ADULT; AGED; BODY MASS; BREAST NEOPLASMS; COLONIC NEOPLASMS; COMPLICATION; ENDOMETRIAL NEOPLASMS; ESTROGEN THERAPY; FEMALE; MALE; MIDDLE AGED; NEOPLASMS; OBSERVATIONAL STUDY; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; PROSPECTIVE STUDY; PROSTATIC NEOPLASMS; RISK; STATISTICAL MODEL;

ADIPOSITY; ADULT; AGED; BODY MASS INDEX; BREAST NEOPLASMS; COLONIC NEOPLASMS; ENDOMETRIAL NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; NEOPLASMS; OBESITY; OBSERVATIONAL STUDY AS TOPIC; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; POSTMENOPAUSE; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RISK; WEIGHT GAIN;

EID: 84927171441     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djv088     Document Type: Review

References (103)

1. World Health Organization. Obesity and overweight. http://www.who.int/mediacentre/factsheets/fs311/en/. Accessed September 1, 2014.
2. Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635-643.
3. American Institute for Cancer Research. Updated Estimate on Obesity-Related Cancers. http://www.aicr.org/cancerresearch-update/2014/march-19/cru-updated-estimate-onobesity-related-cancers.html. Accessed September 1, 2014.
4. The U. S. National Cancer Institute. Obesity and Cancer Risk. http://www.cancer.gov/cancertopics/factsheet/Risk/obesity. Accessed September 1, 2014.
5. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr. 2007;86(3):556-565.
6. Renehan AG, Tyson M, Egger M, et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569-578.
7. Discacciati A, Orsini N, Wolk A. Body mass index and incidence of localized and advanced prostate cancer-A doseresponse meta-analysis of prospective studies. Ann Oncol. 2012;23(7):1665-1671.
8. Cheraghi Z, Poorolajal J, Hashem T, et al. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS One. 2012;7(12):e51446.
9. Crosbie EJ, Zwahlen M, Kitchener HC, et al. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(12):3119-3130.
10. Mathew A, George PS, Ildaphonse G. Obesity and kidney cancer risk in women: a meta-analysis (1992-2008). Asian Pac J Cancer Prev. 2009;10(3):471-478.
11. Ildaphonse G, George PS, Mathew A. Obesity and kidney cancer risk in men: a meta-analysis (1992-2008). Asian Pac J Cancer Prev. 2009;10(2):279-286.
12. Aune D, Greenwood DC, Chan DS, et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies. Ann Oncol. 2012;23(4):843-852.
13. Larsson SC, Wolk A. Obesity and the risk of gallbladder cancer: a meta-analysis. Br J Cancer. 2007;96(9):1457-1461.
14. Beral V, Hermon C, Peto R, et al. Ovarian Cancer and Body Size: Individual Participant Meta-Analysis Including 25, 157 Women with Ovarian Cancer from 47 Epidemiological Studies. Plos Med. 2012;9 (4).
15. Kitahara CM, Platz EA, Freeman LEB, et al. Obesity and Thyroid Cancer Risk among US Men and Women: A Pooled Analysis of Five Prospective Studies. Cancer Epidemiol Biomarkers Prev. 2011;20(3):464-472.
16. Malhotra R, Ostbye T, Riley CM, et al. Young adult weight trajectories through midlife by body mass category. Obesity (Silver Spring). 2013;21(9):1923-1934.
17. Ballard-Barbash R. Anthropometry and breast cancer. Body size-A moving target. Cancer. 1994;74(3 Suppl):1090-1100.
18. Hu F. Obesity Epidemiology. New York, NY: Oxford University Press, 2008.
19. Lebovitz HE. The relationship of obesity to the metabolic syndrome. Int J Clin Pract Suppl. 2003;(134):18-27.
20. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283(15):2008-2012.
21. Renehan AG, Flood A, Adams KF, et al. Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort. Am J Epidemiol. 2012;176(12):1130-1140.
22. Thygesen LC, Gronbaek M, Johansen C, et al. Prospective weight change and colon cancer risk in male US health professionals. Int J Cancer. 2008;123(5):1160-1165.
23. Alsaker MD, Janszky I, Opdahl S, et al. Weight change in adulthood and risk of postmenopausal breast cancer: the HUNT study of Norway. Br J Cancer. 2013;109(5):1310-1317.
24. Eliassen AH, Colditz GA, Rosner B, et al. Adult weight change and risk of postmenopausal breast cancer. JAMA. 2006;296(2):193-201.
25. Geer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6(Suppl 1):60-75.
26. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11(12):1531-1543.
27. Colditz GA. Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst. 1998;90(11):814-823.
28. Ho SM. Estrogen, progesterone and epithelial ovarian cancer. Reprod Biol Endocrinol. 2003;1:73.
29. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Breast Cancer. Continuous Update Project Report Summary, 2010.
30. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135(11):1301-1309.
31. White KK, Park SY, Kolonel LN, et al. Body size and breast cancer risk: the Multiethnic Cohort. Int J Cancer. 2012;131(5):E705-E716.
32. Hamling J, Lee P, Weitkunat R, et al. Facilitating meta-analyses by deriving relative effect and precision estimates for alternative comparisons from a set of estimates presented by exposure level or disease category. Stat Med. 2008;27(7):954-970.
33. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
34. Bagnardi V, Zambon A, Quatto P, et al. Flexible meta-regression functions for modeling aggregate dose-response data, with an application to alcohol and mortality. Am J Epidemiol. 2004;159(11):1077-1086.
35. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
36. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
37. Sterne JA, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53(11):1119-1129.
38. Harbord RM, Egger M, Sterne JAC. A modified test for small study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25(20):3443-3457.
39. Kawai M, Minami Y, Kuriyama S, et al. Adiposity, adult weight change and breast cancer risk in postmenopausal Japanese women: the Miyagi Cohort Study. Br J Cancer. 2010;103(9):1443-1447.
40. Van Den Brandt PA, Dirx MJ, Ronckers CM, et al. Height, weight weight change, and postmenopausal breast cancer risk: The Netherlands Cohort Study. Cancer Causes Control. 1997;8(1):39-47.
41. Radimer KL, Ballard-Barbash R, Miller JS, et al. Weight change and the risk of late-onset breast cancer in the original Framingham cohort. Nutr Cancer. 2004;49(1):7-13.
42. Sweeney C, Blair CK, Anderson KE, et al. Risk factors for breast cancer in elderly women. Am J Epidemiol. 2004;160(9):868-875.
43. Breslow RA, Ballard-Barbash R, Munoz K, et al. Long-term recreational physical activity and breast cancer in the National Health and Nutrition Examination Survey I epidemiologic follow-up study. Cancer Epidemiol Biomarkers Prev. 2001;10(7):805-808.
44. Krishnan K, Bassett JK, MacInnis RJ, et al. Associations between weight in early adulthood, change in weight, and breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2013;22(8):1409-1416.
45. Feigelson HS, Jonas CR, Teras LR, et al. Weight gain, body mass index, hormone replacement therapy, and postmenopausal breast cancer in a large prospective study. Cancer Epidemiol Biomarkers Prev. 2004;13(2):220-224.
46. Palmer JR, Adams-Campbell LL, Boggs DA, et al. A prospective study of body size and breast cancer in black women. Cancer Epidemiol Biomarkers Prev. 2007;16(9):1795-1802.
47. Lahmann PH, Schulz M, Hoffmann K, et al. Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer. 2005;93(5):582-589.
48. Ahn J, Schatzkin A, Lacey JV Jr, et al. Adiposity, adult weight change, and postmenopausal breast cancer risk. Arch Intern Med. 2007;167(19):2091-2102.
49. Michels KB, Terry KL, Eliassen AH, et al. Adult weight change and incidence of premenopausal breast cancer. Int J Cancer. 2012;130(4):902-909.
50. Bassett JK, Severi G, Baglietto L, et al. Weight change and prostate cancer incidence and mortality. Int J Cancer. 2012;131(7):1711-1719.
51. Chamberlain C, Romundstad P, Vatten L, et al. The association of weight gain during adulthood with prostate cancer incidence and survival: a population-based cohort. Int J Cancer. 2011;129(5):1199-1206.
52. Rodriguez C, Freedland SJ, Deka A, et al. Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev. 2007;16(1):63-69.
53. Littman AJ, White E, Kristal AR. Anthropometrics and prostate cancer risk. Am J Epidemiol. 2007;165(11):1271-1279.
54. Aleksandrova K, Pischon T, Buijsse B, et al. Adult weight change and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Eur J Cancer. 2013;49(16):3526-3536.
55. Bassett JK, Severi G, English DR, et al. Body size, weight change, and risk of colon cancer. Cancer Epidemiol Biomarkers Prev. 2010;19(11):2978-2986.
56. Laake I, Thune I, Selmer R, et al. A prospective study of body mass index, weight change, and risk of cancer in the proximal and distal colon. Cancer Epidemiol Biomarkers Prev. 2010;19(6):1511-1522.
57. Canchola AJ, Chang ET, Bernstein L, et al. Body size and the risk of endometrial cancer by hormone therapy use in postmenopausal women in the California Teachers Study cohort. Cancer Causes Control. 2010;21(9):1407-1416.
58. Chang SC, Lacey JV Jr, Brinton LA, et al. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study. Cancer Epidemiol Biomarkers Prev. 2007;16(4):723-730.
59. Friedenreich C, Cust A, Lahmann PH, et al. Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition. Cancer Causes Control. 2007;18(4):399-413.
60. Ma X, Beeghly-Fadiel A, Shu XO, et al. Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women's Health Study. Br J Cancer. 2013;109(3):751-755.
61. Canchola AJ, Chang ET, Bernstein L, et al. Body size and the risk of ovarian cancer by hormone therapy use in the California Teachers Study cohort. Cancer Causes Control. 2010;21(12):2241-2248.
62. Schouten LJ, Goldbohm RA, Van Den Brandt PA. Height, weight, weight change, and ovarian cancer risk in the Netherlands cohort study on diet and cancer. Am J Epidemiol. 2003;157(5):424-433.
63. Patel AV, Rodriguez C, Bernstein L, et al. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U. S. Cohort. Cancer Epidemiol Biomarkers Prev. 2005;14(2):459-466.
64. Isaksson B, Jonsson F, Pedersen NL, et al. Lifestyle factors and pancreatic cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer. 2002;98(3):480-482.
65. Catsburg C, Kirsh VA, Soskolne CL, et al. Associations between anthropometric characteristics, physical activity, and breast cancer risk in a Canadian cohort. Breast Cancer Res Treat. 2014;145(2):545-552.
66. Hernandez BY, Park SY, Wilkens LR, et al. Relationship of body mass, height, and weight gain to prostate cancer risk in the multiethnic cohort. Cancer Epidemiol Biomarkers Prev. 2009;18(9):2413-2421.
67. Wright ME, Chang SC, Schatzkin A, et al. Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer. 2007;109(4):675-684.
68. Jonsson F, Wolk A, Pedersen NL, et al. Obesity and hormonedependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer. 2003;106(4):594-599.
69. Giovannucci E, Rimm EB, Stampfer MJ, et al. Height, body weight, and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(8):557-563.
70. Larsson SC, Rutegard J, Bergkvist L, et al. Physical activity, obesity, and risk of colon and rectal cancer in a cohort of Swedish men. Eur J Cancer. 2006;42(15):2590-2597.
71. Martinez ME, Giovannucci E, Spiegelman D, et al. Leisuretime physical activity, body size, and colon cancer in women. Nurses' Health Study Research Group. J Natl Cancer Inst. 1997;89(13):948-955.
72. Lahmann PH, Cust AE, Friedenreich CM, et al. Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2010;126(10):2404-2415.
73. Fairfield KM, Willett WC, Rosner BA, et al. Obesity, weight gain, and ovarian cancer. Obstet Gynecol. 2002;100(2):288-296.
74. Johansen D, Borgstrom A, Lindkvist B, et al. Different markers of alcohol consumption, smoking and body mass index in relation to risk of pancreatic cancer. A prospective cohort study within the Malmo Preventive Project. Pancreatology. 2009;9(5):677-686.
75. Luo J, Margolis KL, Adami HO, et al. Obesity and risk of pancreatic cancer among postmenopausal women: the Women's Health Initiative (United States). Br J Cancer. 2008;99(3):527-531.
76. Kitahara CM, Platz EA, Park Y, et al. Body fat distribution, weight change during adulthood, and thyroid cancer risk in the NIH-AARP Diet and Health Study. Int J Cancer. 2012;130(6):1411-1419.
77. Kabat GC, Kim MY, Thomson CA, et al. Anthropometric factors and physical activity and risk of thyroid cancer in postmenopausal women. Cancer Causes Control. 2012;23(3):421-430.
78. Iribarren C, Haselkorn T, Tekawa IS, et al. Cohort study of thyroid cancer in a San Francisco Bay area population. Int J Cancer. 2001;93(5):745-750.
79. Adams KF, Leitzmann MF, Albanes D, et al. Body size and renal cell cancer incidence in a large US cohort study. Am J Epidemiol. 2008;168(3):268-277.
80. Luo J, Margolis KL, Adami HO, et al. Body size, weight cycling, and risk of renal cell carcinoma among postmenopausal women: the Women's Health Initiative (United States). Am J Epidemiol. 2007;166(7):752-759.
81. Van Kruijsdijk RC, Van Der Wall E, Visseren FL. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev. 2009;18(10):2569-2578.
82. Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 2004;350(10):991-1004.
83. Nelson HD, Humphrey LL, Nygren P, et al. Postmenopausal hormone replacement therapy: scientific review. JAMA. 2002;288(7):872-881.
84. Vrieling A, Buck K, Kaaks R, et al. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis. Breast Cancer Res Treat. 2010;123(3):641-649.
85. Feigelson HS, Patel AV, Teras LR, et al. Adult weight gain and histopathologic characteristics of breast cancer among postmenopausal women. Cancer. 2006;107(1):12-21.
86. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
87. Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol. 2001;45(3 Suppl):S116-S124.
88. Toth MJ, Tchernof A, Sites CK, et al. Menopause-related changes in body fat distribution. Ann N Y Acad Sci. 2000;904:502-506.
89. Michels KB, Terry KL, Willett WC. Longitudinal study on the role of body size in premenopausal breast cancer. Arch Intern Med. 2006;166(21):2395-2402.
90. Potischman N, Swanson CA, Siiteri P, et al. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst. 1996;88(11):756-758.
91. Donohoe CL, Doyle SL, Reynolds JV. Visceral adiposity, insulin resistance and cancer risk. Diabetol Metab Syndr. 2011;3:12.
92. Lin JH, Zhang SM, Rexrode KM, et al. Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol. 2013;11(4):419-424, e411.
93. Dhindsa S, Miller MG, McWhirter CL, et al. Testosterone concentrations in diabetic and nondiabetic obese men. Diabetes Care. 2010;33(6):1186-1192.
94. Hsing AW, Sakoda LC, Chua S Jr. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr. 2007;86(3):S843-S857.
95. Freedland SJ, Platz EA. Obesity and prostate cancer: making sense out of apparently conflicting data. Epidemiol Rev. 2007;29:88-97.
96. De Mutsert R, Sun Q, Willett WC, et al. Overweight in early adulthood, adult weight change, and risk of type 2 diabetes, cardiovascular diseases, and certain cancers in men: a cohort study. Am J Epidemiol. 2014;179(11):1353-1365.
97. Niedhammer I, Bugel I, Bonenfant S, et al. Validity of self-reported weight and height in the French GAZEL cohort. Int J Obes Relat Metab Disord. 2000;24(9):1111-1118.
98. Stevens J, Keil JE, Waid LR, et al. Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol. 1990;132(6):1156-1163.
99. Perry GS, Byers TE, Mokdad AH, et al. The validity of self-reports of past body weights by U. S. adults. Epidemiology. 1995;6(1):61-66.
100. Palta M, Prineas RJ, Berman R, et al. Comparison of self-reported and measured height and weight. Am J Epidemiol. 1982;115(2):223-230.
101. Freedman LS, Schatzkin A, Midthune D, et al. Dealing with dietary measurement error in nutritional cohort studies. J Natl Cancer Inst. 2011;103(14):1086-1092.
102. Tamakoshi K, Yatsuya H, Kondo T, et al. The accuracy of long-term recall of past body weight in Japanese adult men. Int J Obes Relat Metab Disord. 2003;27(2):247-252.
103. Mozaffarian D, Hao T, Rimm EB, et al. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364(25):2392-2404.